Covid 19 Research using Clinical Trials (Home Page)
Report for D011618: Psychotic Disorders NIH
(Synonyms: Psychot, Psychotic Dis, Psychotic Disord, Psychotic Disorde, Psychotic Disorder, Psychotic Disorders)
Developed by Shray Alag
Clinical Trial MeSH HPO Drug Gene SNP Protein Mutation
Correlated Drug Terms (3)
| Name (Synonyms) | Correlation | |
|---|---|---|
| drug1068 | Pre_lunch pranayama Wiki | 1.00 |
| drug1067 | Pre_dinner pranayama Wiki | 1.00 |
| drug840 | Morning pranayama Wiki | 1.00 |
Correlated MeSH Terms (3)
| Name (Synonyms) | Correlation | |
|---|---|---|
| D001523 | Mental Disorders NIH | 0.33 |
| D045169 | Severe Acute Respiratory Syndrome NIH | 0.06 |
| D018352 | Coronavirus Infections NIH | 0.05 |
Correlated HPO Terms (0)
| Name (Synonyms) | Correlation |
|---|
There is one clinical trial.
Clinical Trials
1 Yoga- Based Breathing for Vagus Nerve Stimolation as Home-care Adjuvant Treatment Against Burden COVID 19 Outbreak
COVID-19 mortality occurs mainly from immunological behavior or by suicide after healing . In both cases, the causal link is coronavirus within the host response. The rationale of use of deep yoga breathing as adjuvant treatment to COVID-19 disease , is linked to the mechanical action to stimulate the vagus nerve through scalene and sternocleidomastoid muscles function of which the continuity of action bring to modulate upto suppress, the inflammatory reflex and pro-inflammatory cytokines overproduction and contestual slowering of the sympathetic stress response as a first cause of sleep and late mental disorders which can increase the annual suicide rate. An easily breathing medical Yoga protocol has been developed to test a cost-effective care provision, training, contact tracing and mass efficacy testing.
NCT04413747 Coronavirus Infection Cytokine Storm Mental Disorder Behavioral: Morning pranayama Behavioral: Pre_lunch pranayama Behavioral: Pre_dinner pranayama MeSH:Coronavirus Infections Severe Acute Respiratory Syndrome Mental Disorders Psychotic Disorders
HPO:Psychosis
Primary Outcomes
Description: COVID 19's Patients mortality all cause incidence proportion
Measure: Mortality Time: 12 months
Description: COVID 19's Patients suicide rate
Measure: Mortality-suicide Time: 12 months
Secondary Outcomes
Description: In-hospital COVID19's Patients oxygen use, invasive ventilation or high flow oxygen devices incidence proportion
Measure: Need of hospitalization for respiratory failure of COVID19's Patients Time: 12 months
Description: At home or telematic incidence proportion of professional psychiatric-psychological interventions for anxiety and depression
Measure: Homecare professional psychiatric-psychological interventions for COVID19's Patients Time: 12 months
Description: Rate of positive scores for depression and anxiety according to the Pittsburgh Sleep Quality Index (PSQI) requiring drug treatment
Measure: Sleep disturbances of COVID 19's Patients as mental disorder Time: 12 months
HPO Nodes
HP:0000709: Psychosis
Genes 117
DCAF17 MKRN3 TRNF LMBRD1 PDE11A MKRN3-AS1 CLN3 TBC1D7 PAH CTLA4 SLC7A7 C9ORF72 SLC12A6 CDH23 NPC2 ATXN7 PDGFB NDN ATP13A2 ALDH5A1 ABCD1 KCNT1 SPART SNORD115-1 TMEM106B CLN8 DNMT1 PWRN1 TRNL1 HFE PUS3 MYORG PDGFB PRKAR1A ZFYVE26 USP8 STAT4 IRAK1 PCDH19 TRNW COX3 SLC6A19 EPM2A GSS NPC1 UPF3B PTPN22 MAPT SLC25A13 VCP TREX1 TRNH COX1 DNASE1 TTC19 C9ORF72 SLC20A2 NDP HERC2 HMBS ND1 ND5 WFS1 PDGFRB ND4 AIP PPOX COX2 TRNS2 ALAD MAGEL2 SOBP C1QA SNRPN TREM2 PWAR1 MED12 ITM2B CACNA1A PAK3 NPAP1 SH2B1 PRNP TRNQ NDP PARK7 PANK2 CBS SPP1 GNAS NAGS FCGR2A GCLC MECP2 SNORD116-1 ACADS PSEN1 IPW MED12 ZDHHC9 PRDM8 PCDH19 FCGR2B TWNK NHLRC1 TRNS1 SQSTM1 DCAF17 ND6 RPS6KA3 ALDH18A1 WFS1 USP8 GRN C1R VPS13A CHMP2B
Primary Outcomes
Description: COVID 19's Patients mortality all cause incidence proportion
Measure: Mortality Time: 12 monthsDescription: COVID 19's Patients suicide rate
Measure: Mortality-suicide Time: 12 monthsSecondary Outcomes
Description: In-hospital COVID19's Patients oxygen use, invasive ventilation or high flow oxygen devices incidence proportion
Measure: Need of hospitalization for respiratory failure of COVID19's Patients Time: 12 monthsDescription: At home or telematic incidence proportion of professional psychiatric-psychological interventions for anxiety and depression
Measure: Homecare professional psychiatric-psychological interventions for COVID19's Patients Time: 12 monthsDescription: Rate of positive scores for depression and anxiety according to the Pittsburgh Sleep Quality Index (PSQI) requiring drug treatment
Measure: Sleep disturbances of COVID 19's Patients as mental disorder Time: 12 months